DFDADECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

Dapagliflozin

Treatment used for 4 conditions

Total Trials
131
Total Participants
295K
Avg Effectiveness
87%
Avg Safety Score
65%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.

Chronic kidney disease due to diabetes mellitus type 2
Effectiveness:92%
Safety:65%
Trials:1
Participants:150K
Chronic kidney disease due to diabetes mellitus type 1
Effectiveness:88%
Safety:65%
Trials:1
Participants:100K
Heart Failure
Effectiveness:88%
Safety:65%
Trials:109
Participants:25K
Alcoholic cardiomyopathy
Effectiveness:80%
Safety:65%
Trials:20
Participants:20K
DECENTRALIZED FRAMEWORK FOR DRUG ASSESSMENT

EVIDENCE-BASED TREATMENT INFORMATION

TREATMENTS

  • CONDITIONS
  • TREATMENTS
  • FIND TRIALS

ABOUT

  • ABOUT
  • RESEARCH & EVIDENCE
  • FAQ

CONTACT

hello@dfda.earth
dFDA.earth

EVIDENCE-BASED TREATMENT INFORMATION

PRIVACY POLICY•TERMS OF SERVICE
© 2025 Mike P. Sinn